STOCK TITAN

Universal Health Realty Income Trust 10-Q Filings

UHT NYSE

Every 10-Q that Universal Health Realty Income Trust (UHT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow UHT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UHT filings page.

Rhea-AI Summary

Universal Health Realty Income Trust, a healthcare-focused REIT with 77 investments in 21 states, reported Q2 2026 revenue of $24,991 thousand, essentially flat year over year, while net income increased to $5,907 thousand and first‑half net income to $10,926 thousand. The improvement was driven by a $724 thousand gain on a Chicago land sale, higher equity income from unconsolidated LLCs and lower interest expense.

UHS-related tenants remained significant, generating about 40% of total revenue and roughly 25% from six UHS hospital leases; UHS also advises the trust and owned 5.7% of its shares. The trust declared and paid first‑half dividends of approximately $20.8 million, or $1.495 per share. At June 30, 2026, total assets were $567,118 thousand and borrowings under the credit facility were $365,550 thousand, within an expanded $475 million capacity. Construction continues on the approximately $34 million Miller Medical Plaza MOB in Florida, supported by a 10‑year master flex lease for about 75% of its space. Interest rate swaps in an accumulated other comprehensive income position of $2,581 thousand help temper floating‑rate exposure, while management emphasizes ongoing risks from higher interest costs, new Medicaid legislation, inflationary pressures on tenants and continued dependence on UHS.

Rhea-AI Summary

Universal Health Realty Income Trust reported stable first-quarter 2026 results. Total revenue was $24.5 million for the three months ended March 31, 2026, essentially unchanged from $24.5 million a year earlier. Net income rose to $5.0 million from $4.8 million, helped mainly by lower interest expense.

Diluted earnings per share increased to $0.36 from $0.34, and funds from operations, a key REIT metric, grew to $12.3 million, or $0.88 per diluted share, from $11.9 million, or $0.86 per share. The Trust paid dividends of $0.745 per share, totaling about $10.3 million.

At March 31, 2026, total assets were $563.8 million and equity was $147.8 million, with $359.5 million outstanding on the credit facility and $18.3 million in non‑recourse mortgage debt. Properties related to Universal Health Services, Inc. generated approximately 41% of consolidated revenues, underscoring the importance of this tenant and advisory relationship.

Rhea-AI Summary

Universal Health Realty Income Trust (UHT) reported steady Q3 2025 results. Revenue was $25.3 million versus $24.5 million a year ago, and net income was $4.0 million, holding diluted EPS at $0.29. For the first nine months, revenue was $74.7 million with net income of $13.3 million, reflecting diluted EPS of $0.96.

Lease revenue from non-related parties was $14.8 million in Q3, while UHS-related lease revenue was $8.4 million, including $895,000 of bonus rent from McAllen Medical Center. Equity in income from unconsolidated LLCs was $438,000. The quarterly dividend was $0.74 per share; year-to-date dividends were $2.215 per share.

On the balance sheet, total assets were $568.0 million and equity was $158.6 million. Borrowings under the $425 million credit facility were $357.1 million, leaving $67.9 million available. UHS-related tenants represented approximately 39% of Q3 revenue. After quarter-end, UHT entered a ground lease to develop an 80,000 sq ft medical office building in Palm Beach Gardens, Florida, estimated to cost $34 million, with a 10-year master flex lease for about 75% of space.

Rhea-AI Summary

Universal Health Realty Income Trust (UHT) reported quarter-to-date operating results that were largely stable but showed a decline in net income versus the prior year period. Total revenue for the three months ended June 30, 2025 was $24.9 million, essentially flat with the prior-year quarter ($24.7 million), and six-month revenue was $49.4 million versus $49.9 million a year earlier. Quarterly net income was $4.5 million (basic EPS $0.33) compared with $5.3 million (EPS $0.38) in Q2 2024; six-month net income declined to $9.3 million from $10.6 million.

The Trust remains highly tied to Universal Health Services (UHS): UHS-related tenants produced approximately 40% of consolidated revenues in the three- and six-month periods. Balance sheet highlights include total assets of $573.0 million, total liabilities of $407.9 million, total equity of $165.2 million, and outstanding borrowings under the credit facility of $354.8 million with $70.2 million available capacity. Cash flow items: net cash provided by operating activities was $25.3 million for the six months; dividends paid were $20.5 million (six months, $1.475/share). The Trust recognized an unrealized derivative loss of $3.7 million year-to-date, which reduced comprehensive income to $5.6 million for the six months.